The Australian TGA Listed medicine (AUST L) is an official registration scheme administered by the Therapeutic Goods Administration (TGA), a division of the Australian Department of Health. Products under this listing are required to be manufactured in TGA-licensed GMP facilities, use only TGA‑approved low‑risk ingredients, and rely on a self‑declaration by the sponsor regarding compliance with safety and quality requirements. Once a product is entered in the Australian Regis

The Australian TGA Listed medicine (AUST L) is an official registration scheme administered by the Therapeutic Goods Administration (TGA), a division of the Australian Department of Health. Products under this listing are required to be manufactured in TGA-licensed GMP facilities, use only TGA‑approved low‑risk ingredients, and rely on a self‑declaration by the sponsor regarding compliance with safety and quality requirements. Once a product is entered in the Australian Regis

The Australian TGA Listed medicine (AUST L) is an official registration scheme administered by the Therapeutic Goods Administration (TGA), a division of the Australian Department of Health. Products under this listing are required to be manufactured in TGA-licensed GMP facilities, use only TGA‑approved low‑risk ingredients, and rely on a self‑declaration by the sponsor regarding compliance with safety and quality requirements. Once a product is entered in the Australian Regis

The Australian TGA Listed medicine (AUST L) is an official registration scheme administered by the Therapeutic Goods Administration (TGA), a division of the Australian Department of Health. Products under this listing are required to be manufactured in TGA-licensed GMP facilities, use only TGA‑approved low‑risk ingredients, and rely on a self‑declaration by the sponsor regarding compliance with safety and quality requirements. Once a product is entered in the Australian Regis

The Australian TGA Listed medicine (AUST L) is an official registration scheme administered by the Therapeutic Goods Administration (TGA), a division of the Australian Department of Health. Products under this listing are required to be manufactured in TGA-licensed GMP facilities, use only TGA‑approved low‑risk ingredients, and rely on a self‑declaration by the sponsor regarding compliance with safety and quality requirements. Once a product is entered in the Australian Regis

The Australian TGA Listed medicine (AUST L) is an official registration scheme administered by the Therapeutic Goods Administration (TGA), a division of the Australian Department of Health. Products under this listing are required to be manufactured in TGA-licensed GMP facilities, use only TGA‑approved low‑risk ingredients, and rely on a self‑declaration by the sponsor regarding compliance with safety and quality requirements. Once a product is entered in the Australian Regis

Life's Flora® GreatBarrier® Mucosal Barriers Restore awarded the Monde Selection Gold Quality Award 2025 Monde Selection is an annual international award, established in 1961. It is the oldest and most authoritative international quality research institute in the world today. Located in Brussels, the heart of Europe, the institute has over 80 internationally renowned experts who are committed to conducting comprehensive evaluations of consumer products. The Monde Selection q

Lactobacillus Ferment Extract PE0301 Won the 2024 NutraIngredients-Asia Award in Microbiome Modulation The NutraIngredients-Asia Awards are revered as the "Oscars of Functional Ingredients" and represent one of the most authoritative recognitions in the global nutraceutical industry. Annually presented across six highly competitive categories with only one winner selected per category, these awards attract premier enterprises from the worldwide health nutrition sector. In 20

The Luxembourg Patent for Invention represents Europe's most stringent pharmaceutical-grade innovation certification. Our formula for alleviating allergies and chronic inflammation has undergone comprehensive examination by the Luxembourg Intellectual Property Office (Patent No.LU505637), demonstrating global novelty, scientific creativity, and industrial applicability. This formula can be used to address common allergic reactions and chronic inflammatory conditions, includin

Lactobacillus Ferment Extract PE0401 Won the 2023 NutraIngredients-Asia Award in Microbiome Modulation The NutraIngredients-Asia Awards are renowned as the "Oscars of Nutraceutical Ingredients" and represent one of the most authoritative awards in the global functional food ingredients sector. Held annually across six exclusive categories with only one winner selected per category, the awards attract fierce competition from top-tier ingredient suppliers worldwide. In 2023, L